25 related articles for article (PubMed ID: 3089681)
1. Novel fluorescence approach for trace quantification of levonorgestrel in breast milk based on click reaction with benzonitrofurazan azide (NBD-AZ).
Aref HA; Salama I; Aboukhatwa SM; Helal MA; Kishk SM; Elgawish MS
Methods Appl Fluoresc; 2023 Dec; 12(1):. PubMed ID: 37992321
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
Coukell AJ; Balfour JA
Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
[TBL] [Abstract][Full Text] [Related]
4. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Shaaban MM; Salem HT; Abdullah KA
Contraception; 1985 Dec; 32(6):623-35. PubMed ID: 3937665
[TBL] [Abstract][Full Text] [Related]
5. Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants.
Abdulla KA; Elwan SI; Salem HS; Shaaban MM
Contraception; 1985 Sep; 32(3):261-6. PubMed ID: 3936675
[TBL] [Abstract][Full Text] [Related]
6. Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth.
Díaz S; Herreros C; Juez G; Casado ME; Salvatierra AM; Miranda P; Peralta O; Croxatto HB
Contraception; 1985 Jul; 32(1):53-74. PubMed ID: 3931973
[TBL] [Abstract][Full Text] [Related]
7. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
Haukkamaa M
Contraception; 1986 Jun; 33(6):559-65. PubMed ID: 3095023
[TBL] [Abstract][Full Text] [Related]
8. ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk.
Shikary ZK; Betrabet SS; Patel ZM; Patel S; Joshi JV; Toddywala VS; Toddywala SP; Patel DM; Jhaveri K; Saxena BN
Contraception; 1987 May; 35(5):477-86. PubMed ID: 3113823
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant, by nursing mothers.
Shaaban MM; Odlind V; Salem HT; Abdullah KA; Gomaa AA
Contraception; 1986 Apr; 33(4):357-63. PubMed ID: 3089681
[TBL] [Abstract][Full Text] [Related]
10. Norplant: subdermal implant system for long-term contraception.
Shoupe D; Mishell DR
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
[TBL] [Abstract][Full Text] [Related]
11. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
12. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
